References
- Alanazi, Alanazi N AI, Almoosa Z, Iqbal Z. First report of coexistence
of sickle cell disease and neurofibromatosis Type 1 in a Saudi patient
with family history of neurofibromatosis Type 1. 2019.
- Vanka P, Tejavath R, Chandra N, Swaroopa D, Subbalaxmi M, Yedla D. A
rare case report of coexistent neurofibromatosis type 1 with sickle
cell beta-plus thalassaemia. Journal of Clinical and Scientific
Research. 2020;9(45).
- CrÈange A, Zeller J, Rostaing-Rigattieri S, et al. Neurological
complications of neurofibromatosis type 1 in adulthood. Brain.
2021;122(3):473-481.
- Segal L, Discepola M. Idiopathic intracranial hypertension and sickle
cell disease: two case reports. Can J Ophthalmol. 2005
Dec;40(6):764-7. doi: 10.1016/S0008-4182(05)80097-3. PMID: 16391644.
- Henry M, Driscoll MC, Miller M, Chang T, Minniti CP. Pseudotumor
Cerebri in Children With Sickle Cell Disease: A Case Series.
2004;113(3):e265-e269.
- Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV,
Babovic-Vuksanovic D, Macedo TA, Stanson A. Vascular abnormalities in
patients with neurofibromatosis syndrome type I: clinical spectrum,
management, and results. J Vasc Surg. 2007 Sep;46(3):475-484. doi:
10.1016/j.jvs.2007.03.055. Epub 2007 Jul 30. PMID: 17681709.
- Booth C, Preston R, Clark G, Reidy J. Management of renal vascular
disease in neurofibromatosis type 1 and the role of percutaneous
transluminal angioplasty. Nephrology Dialysis
Transplantation. 2002;17(7):1235-1240.
- Serafini NB SC, Vinhas AS, Godinho MB. Moyamoya syndrome associated
with neurofibromatosis type 1 in a pediatric patient.
2017;92(6):870-873.
- Usmani A, Machado RF. Vascular complications of sickle cell
disease. Clin Hemorheol Microcirc . 2018;68(2-3):205-221.
doi:10.3233/CH-189008
- Jutant E-M, Girerd B, JaÔs X, et al. Pulmonary hypertension associated
with neurofibromatosis type 1. 2018;27.
- Benneh-Akwasi Kuma A O-AAM, Sey F, Olayemi E, Nouraie M, et al.
Prevalence of relative systemic hypertension in adults with sickle
cell disease in Ghana. 2018;13(1).
- Mercille G, Ospina LH. Pediatric Idiopathic Intracranial Hypertension.
2007;28(11):e77-e86.
- Rahimi Z, Parsian A. Sickle cell disease and venous thromboembolism.
Mediterr J Hematol Infect Dis. 2011;3(1):e2011024. doi:
10.4084/MJHID.2011.024. Epub 2011 May 24. PMID: 21713075; PMCID:
PMC3113276.
- Terry AR, Jordan JT, Schwamm L, Plotkin SR. Increased Risk of
Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1:
Population-Based Approach. Stroke. 2016 Jan;47(1):60-5. doi:
10.1161/STROKEAHA.115.011406. Epub 2015 Dec 8. PMID: 26645253.
- Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Viaño
J, Carceller-Benito F. Estenosis del acueducto de Silvio en la
neurofibromatosis tipo 1. Presentación de 19 pacientes infantiles
[Aqueductal stenosis in the neurofibromatosis type 1. Presentation
of 19 infantile patients]. Rev Neurol. 2007 Jul 1-15;45(1):18-21.
Spanish. PMID: 17620261.
- Rigano P, Pecoraro A, Calvaruso G, Steinberg MH, Iannello S, Maggio A.
Cerebrovascular events in sickle cell-beta thalassemia treated with
hydroxyurea: a single center prospective survey in adult Italians. Am
J Hematol. 2013 Nov;88(11):E261-4. doi: 10.1002/ajh.23531. Epub 2013
Aug 30. PMID: 23828131.
- Chamouine A ST, Muszlak M, et al. High fetal hemoglobin level is
associated with increased risk of cerebral vasculopathy in children
with sickle cell disease in Mayotte. BMC Pediatr. 2020;20(1):302.